ONYX-101
A Phase II Study of Onyxatinib in Advanced NSCLC
Phase
Phase II
Indication
Non-Small Cell Lung Cancer (NSCLC)
Claim Type
Efficacy
Design
Single Arm
This is a sample study loaded for demonstration purposes. In the full platform, you define your own study details, objectives, population, visit schedule, and analysis plan.